A compound of formula (II) or a pharmaceutically acceptable salt thereof, wherein: ** Formula ** W, X, Y and Z are each independently selected from CH or N； D and D1 are independently selected from a link or NRb； L is a bond, -C (O) -, - (CRcRc) m-, -OC (O) -, - (CRcRc) m-OC (O) -, - (CRcRc) mC (O) -, -NRbC (S) - or -NRbC (O) -； R1 is selected from alkyl, cycloalkyl, aryl, heteroaryl and heterocyclyl； each of which is substituted with 0-5 occurrences of Rd； each R3 is independently selected from halo, haloalkyl, alkyl, hydroxyl and -ORa； each Ra is independently selected from alkyl, acyl, hydroxyalkyl and haloalkyl； each Rb is independently selected from hydrogen and alkyl； each Rc is independently selected from hydrogen, halo, alkyl, alkoxy and halo alkoxy or two Rc taken together with the carbon atoms to which they are attached form an optionally substituted cycloalkyl； each Rd is independently selected from halo, haloalkyl, haloalkoxy, alkyl, alkynyl, nitro, cyano, hydroxyl, -C (O) Ra, -OC (O) Ra, -C (O) ORa, -SRa, -NRaRb and - ORa, or two Rd taken together with the carbon atoms to which they are attached form an optionally substituted heterocyclyl； n is 0, 1 or 2； m is 1, 2 or 3； h is 1； and g is 1.Un compuesto de fórmula (II) o una sal farmacéuticamente aceptable del mismo, en donde:**Fórmula** W, X, Y y Z se seleccionan cada uno independientemente entre CH o N； D y D1 se seleccionan independientemente entre un enlace o NRb； L es un enlace, -C(O)-, -(CRcRc)m-, -OC(O)-, -(CRcRc)m-OC(O)-, -(CRcRc)m-C(O)-, -NRbC(S)- o -NRbC(O)-； R1 se selecciona entre alquilo, cicloalquilo, arilo, heteroarilo y heterociclilo； cada uno de los cuales está sustituido con 0-5 apariciones de Rd； cada R3 se selecciona independientemente entre halo, haloalquilo, alquilo, hidroxilo y -ORa； cada Ra se selecciona independientemente entre alquilo, acilo, hidroxialquilo y haloalquilo； cada Rb se selecciona independientemente entre hidrógeno y alquilo； cada Rc se selecciona independientemente
